FCMI

Foresite Capital Management II Portfolio holdings

AUM $29.2M
This Quarter Return
-1.06%
1 Year Return
+44.84%
3 Year Return
-66.21%
5 Year Return
-37.37%
10 Year Return
AUM
$146M
AUM Growth
+$146M
Cap. Flow
-$46.9M
Cap. Flow %
-32.08%
Top 10 Hldgs %
94.95%
Holding
19
New
Increased
4
Reduced
8
Closed
3
Name Market Value Portfolio Weight Shares or Principal Shares
Change %
Capital Flow
AIMT
1
DELISTED
Aimmune Therapeutics, Inc.
AIMT
$42.9M 29.35% 3,967,900 -120,000 -3% -$1.3M
UAM
2
DELISTED
Universal American Corp
UAM
$21.3M 14.59% 2,814,883
AERI
3
DELISTED
Aerie Pharmaceuticals, Inc.
AERI
$17.2M 11.73% 975,285 +25,913 +3% +$456K
ALDR
4
DELISTED
Alder Biopharmaceuticals, Inc.
ALDR
$15M 10.26% 600,929 +70,513 +13% +$1.76M
EPZM
5
DELISTED
Epizyme, Inc
EPZM
$12.2M 8.34% 1,191,995
NSTG
6
DELISTED
NanoString Technologies, Inc.
NSTG
$9.17M 6.27% 727,857 +68,371 +10% +$861K
ADAP
7
Adaptimmune Therapeutics
ADAP
$15.6M
$8.6M 5.88% 1,054,864 -706,703 -40% -$5.76M
LRMR icon
8
Larimar Therapeutics
LRMR
$310M
$4.55M 3.11% 760,046 -662,227 -47% -$3.97M
NVET
9
DELISTED
Nexvet Biopharma plc Ordinary Shares
NVET
$4.18M 2.86% 900,155 +12,354 +1% +$57.3K
ARDX icon
10
Ardelyx
ARDX
$1.53B
$3.75M 2.56% 428,989 -39,308 -8% -$343K
OREX
11
DELISTED
Orexigen Therapeutics, Inc.
OREX
$2.33M 1.6% 5,427,559 -1,034,521 -16% -$445K
XLRN
12
DELISTED
Acceleron Pharma Inc.
XLRN
$1.66M 1.13% 48,839 -125,250 -72% -$4.26M
NDRM
13
DELISTED
NeuroDerm Ltd. Ordinary Shares
NDRM
$1.35M 0.92% 83,211 -36,570 -31% -$594K
RGNX icon
14
Regenxbio
RGNX
$451M
$1.25M 0.86% 156,741
BDSI
15
DELISTED
BioDelivery Sciences International, Inc.
BDSI
$791K 0.54% 335,239 -408,156 -55% -$963K
RGLS
16
DELISTED
Regulus Therapeutics
RGLS
-2,038,939 Closed -$14.1M
SCYX icon
17
SCYNEXIS
SCYX
$34.9M
-337,177 Closed -$1.36M
KDNY
18
DELISTED
Chinook Therapeutics, Inc. Common Stock
KDNY
-1,322,916 Closed -$16.9M
ANAC
19
DELISTED
ANACOR PHARMACEUTICALS INC COM
ANAC
0